TruthArchive.ai - Related Video Feed

Kevin McKernan provides a whirlwind tour of DNA contamination in vaccines. He highlights the existence of DNA contamination in vaccines based on various studies and documents. McKernan criticizes the regulators' response, stating that they have turned to the vaccine manufacturers for answers, which he believes are misleading. He also discusses the use of different measurement methods and the potential risks associated with DNA contamination, including the integration of foreign DNA into human cells. McKernan calls for further screening of various biological samples for vaccine residue and encourages CLIA Laboratories to take an interest in this matter.

Quan et al demonstrated that the introduction of DNA into a cell, even without integration, can trigger the oncogenic cGAS-STING pathway. The speaker claims that the presence of an SV40 origin of replication, a mammalian origin, in a vaccine grown in E. coli is reckless because it allows the plasmid DNA to replicate episomally in the host. The speaker alleges evidence suggests Pfizer, unlike Moderna, may have included this origin of replication due to carelessness. The speaker highlights concerns about nucleic acid persistence, noting that RT-PCR methods used in studies like Krausson and Rolchen may have amplified both DNA and RNA. The speaker suggests that prior studies assumed detected nucleic acids were RNA, but that further investigation using primers specific to the plasmid backbone might reveal the presence of residual plasmid DNA. The Krausson paper found nucleic acids present for thirty days in heart tissues, and the Rolchen paper found them for sixty days.

Tokyo Institute of Technology Professor Emeritus Murakami discusses the issue of DNA contamination in mRNA vaccines. Multiple researchers have reported the presence of DNA in these vaccines, including LANW0RDS sequences that can activate genes and increase the risk of cancer. The mRNA vaccines also contain spike protein genes that can remain in stem cells and continuously produce spike proteins, leading to immune system suppression and potential health problems. The induction of IGG4 antibodies by the vaccines can further disrupt the immune system and increase the risk of cancer. The presence of more DNA in the vaccines can intensify adverse reactions. The possibility of impurities, such as DNA, in different vaccine batches is a concern. Overall, DNA should not be present in vaccines.

A study comparing gene profiles of 800 healthy individuals to mRNA-injured individuals found severe genetic dysregulation in the latter. Seven of the injured individuals developed new-onset cancers within a year of mRNA injection, while three experienced cardiovascular or long vaccine syndrome. Gene expression comparisons revealed thousands of dysregulated gene expressions in the mRNA-injured, linked to mitochondrial failure and oncogenic activations. Cancer suppression genes were not being suppressed, and immune dysregulation was observed. The study claims to be the first to show long-term genetic disruptions in the vaccinated, indicating molecular chaos within cells. This may be the biological mechanism behind cardiovascular and carcinogenic issues seen in the vaccinated, possibly due to genomic integration of DNA plasmids from the manufacturing process. The speaker states that this is a landmark report and calls for further investigation into the effects on the population, noting that a large percentage of the global population received COVID vaccines.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

Kevin McKernan, a genomics expert, discusses the contamination found in mRNA vaccines. He explains that the vaccines on the market differ from those used in clinical trials, with different levels of contamination. The contamination includes plasmid and bacterial DNA, as well as lipopolysaccharides, which can cause adverse reactions. McKernan reveals that certain functional DNA components were intentionally omitted from the plasmid map submitted to regulators. He emphasizes that the vaccines contain a significant amount of contaminating DNA, which is not easily degraded due to its encapsulation in lipid nanoparticles. McKernan's findings have been replicated by various researchers, highlighting the need for further investigation into the potential risks associated with this contamination.

Many labs, including Medicinal Genomics, found DNA contamination in Pfizer and Moderna mRNA vaccines. Regulators like the FDA and EMA admitted to this, but downplayed its significance. The SP 40 sequences omitted by Pfizer are crucial. DNA contamination can cause insertional mutagenesis, as stated in Moderna's patents. Regulatory agencies were deceived and failed to properly address the issue. This poses a serious risk that cannot be ignored.

Chakrabarty reviewed the Ryan et al and Odek studies, mapping reads to plasmids and finding significant spike sequence from RNA, and less from plasmid DNA, which is expected. RNA sequencing protocols suppress DNA, yet DNA is still present. The Odek study shows the entire vector backbone covered with sequencing reads, indicating heavy contamination and the presence of SV40 promoters in patients. This is evidenced across multiple studies. The Novel study had a lighter density of reads, but some plasmid DNA was detectable. The Lee et al study also showed some SV40 reads. These are more apparent in samples taken closer to vaccination, despite DNA suppression methods. A mice study on vaccine redentilation showed poly A tails regenerate, potentially lengthening RNA lifespan, but DNA contamination was also present.

The speaker claims that this is not conspiracy theory and cites a BMJ publication by Retzaf Levy, which describes a process in vaccine development: vaccines were trialed under one formulation, but when the decision was made to deploy them globally, the process was changed and the product injected to the rest of the world. The speaker asserts that changing the process requires new trials, yet the EMA asked for an additional trial of 250 people after the process change, and that data was never delivered. This is described as a “bait and switch,” asserted as crucial for understanding why trial data is of zero consequence to what’s seen in the field, implying that real-world outcomes do not match trial data and that the numbers from trials are a caricature of field performance. The speaker claims Pfizer had early data indicating what would happen and acted on that by acquiring cancer companies: $43,000,000,000 into the acquisition of C Gen and $2,260,000,000 to acquire Trillium Therapeutics. Trillium is described as focused on blood cancers with the CD147 marker (CD Adaptor 147) on them, a marker claimed to be known to be involved in COVID. The implication is that Pfizer is building an investment portfolio in cancer companies that would benefit from the consequences the speaker alleges they caused. In summary, the vaccines on the market are said to be not the same formulation as what was tested in clinical trials, labeling this a “bait and switch” and a fraud, and asserting that vaccine effectiveness numbers are not reliable because the products differ from trial formulations and because those numbers decay over time. The speaker alleges significant DNA contamination, stating that 10 out of 11 studies have found this, with the remaining studies allegedly constrained by financial conflicts. The claim is that consensus among real studies supports DNA contamination, with several studies through peer review, which the speaker notes is difficult for those papers to pass through peer review. It is claimed that five peer-reviewed studies not originally examining contamination found DNA in blood and tissue upon sleuthing. The speaker asserts that cancer is on the rise and that several papers report cancer post-vaccination, including neoplasms at the site of injection. The claim is that this situation cannot be dismissed as coincidence and is described as “liability free” and often mandated. The speaker posits that this may be the largest carcinogenic hit to the human population, with vaccines on childhood schedules and given to pregnant women, stating that “this has gone absolutely off the rails.”

Speaker 1 reports evidence from multiple sources, including InModia lab in Germany and John Cantazaro at NEO7 Bioscience, that Pfizer and Moderna code is reverse transcribed and inserted into human DNA. According to Speaker 1, this means individuals could carry a "stamp" of Pfizer or Moderna in their genome. The speaker suggests the body may not be editing out or repressing this code, as spike protein evidence persists for years. Transmission of spike protein producing genetic code is possible, along with fragments of code for the spike protein, SV40, and other DNA fragments. Speaker 1 raises concerns about potential health issues like blood clots, heart damage, autoimmunity, and unusual tumors. John Cantazaro's research indicates a dramatically altered genetic profile in vaccinated individuals, tilting towards neoplasm or cancer. Speaker 1 shares an anecdote about a patient who developed terminal cancer after vaccination, with Cantazaro confirming the presence of Pfizer code in the patient's genome.

The speaker discusses DNA contamination found in Pfizer and Moderna mRNA vaccines, highlighting regulatory agencies' failure to address the issue. They mention potential risks of DNA integration and cancer development, urging for a review of regulatory practices. Concerns are raised about DNA levels exceeding limits, potential cell integration, and long-term presence in the body. The speaker emphasizes the need for better monitoring tools and the unique nature of DNA contamination in these vaccines.

Kevin McKernan, Chief Science Officer and Founder of Medicinal Genomics, discusses his research on DNA plasmids found in Moderna and Pfizer COVID-19 vaccines. The DNA contamination in the vaccines is concerning due to potential long-term effects and the risk of genome integration. McKernan highlights the lack of quality control and transparency in the manufacturing process. He also raises concerns about the potential for prothrombotic effects and the presence of an oncogenic virus promoter in the DNA. McKernan emphasizes the need for further research and replication of his findings to better understand the extent of DNA contamination in the vaccines.

I'm Philippe Boucalt, a cancer genomics researcher at the University of South Carolina. I've sequenced the DNA in the Pfizer vaccine and found that it contains fragments of DNA. This DNA could potentially cause rare but serious side effects, such as cardiac arrest and future cancer risks. The regulatory process that allowed this contamination is concerning. The DNA could integrate into long-lived somatic cells and potentially cause autoimmune attacks or disrupt tumor suppressors. To produce the vaccine, they cloned the PCR product into a plasmid vector, which led to the contamination. We can easily measure the amount of this substance in the vaccine and should conduct further studies to understand its implications. The FDA should require Pfizer to remove the DNA from the vaccine.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification and autoimmune attacks. There is a theoretical risk of future cancer as well. The speaker emphasizes the need to investigate these concerns further.

The speaker discusses the finding of plasmids in Pfizer vaccines, referencing a widely read paper that initiated inquiry into the consequences of this residual contaminant. David Speaker replicated this work in Canada, finding it in every one of over 30 vials. Philip Buchholz replicated this in South Carolina, and Dr. Sid Lee replicated the work using different primers and Sanger sequencing. Bridget Koning has replicated this in Germany, and several federal agencies have admitted the presence of DNA, though disagreeing on clinical implications. Ulrich Kammerer's lab replicated the work, transfecting plasmids from the vaccines into cell lines, where they persisted for several cycles of cell division. High schoolers interning at the FDA White Oak facility also measured it and found it to be significantly over the limit. Numerous studies have replicated these findings, with most finding levels over the limit. One individual with ties to Moderna claims it is not over the limit. Kaiser et al. claimed to have found it slightly over the limit but deemed it inconsequential; however, their DNA isolation method has been refuted by Kommer and Konig.

"Pfizer vaccine is contaminated with plasma DNA. It's not just mRNA." "This DNA is the DNA vector that was used as the template for the in vitro transcription reaction when they made the mRNA." "I sequenced it in my own lab." "The vials of Pfizer vaccine that were given out here in Colombia, one of my colleagues was in charge of that vaccination program in the College of Pharmacy." "And for reasons that I still don't understand, he kept every single vial." "So he had a whole freezer full of the empty vials." "And I checked these two batches, and I checked them by sequencing." "It's surprising that there's any DNA in there." "This DNA, in my view, it could be causing some of the rare but serious side effects like death from cardiac arrest."

The speaker, a viral immunologist, discusses the presence of bacterial plasma DNA in the Pfizer and Moderna COVID-19 vaccines. They explain that the DNA is not supposed to be there and that its presence indicates improper manufacturing. The speaker highlights the potential dangers of bacterial DNA, including its ability to activate the immune system and promote inflammation. They also suggest that the DNA could lead to prolonged expression of the spike protein and raise concerns about legal immunity for the manufacturers. The speaker calls for a worldwide moratorium on the technology until further research is conducted.

The Pfizer vaccine contains not only mRNA but also plasma DNA from the vector used in its production. I sequenced samples from two batches of the vaccine in Colombia and found this DNA, which raises concerns about potential health risks. This DNA could integrate into the genomic DNA of cells, leading to permanent changes. Such integration poses theoretical risks, including autoimmune responses and cancer, depending on where the DNA inserts itself in the genome. While these risks may be rare, they warrant investigation to understand their implications better.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

Kevin discovered that the vials used for vaccines are contaminated with bacterial DNA. This is concerning because the modified RNA used in these vaccines creates unusual genetic structures that don't occur naturally. Normally, DNA is in a double helix form, but with modified RNA, there are three strands attached to the DNA. The enzyme used to remove DNA, called DNase, cannot digest these triple-stranded genetic constructs, resulting in DNA contamination in the shots. Pfizer and Moderna should have addressed this issue during the manufacturing process by using different enzymes. This shows that assumptions cannot be made when working with new, unnatural products. The DNA used to manufacture the modified RNA was not properly removed, leading to multiple scary aspects of contamination.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification, autoimmune attacks, or even future cancer. The speaker acknowledges that these concerns are theoretical but believes they warrant further investigation.

The speaker discusses claims about modified RNA (MOD RNA) vaccines and DNA contamination in plasmids. They state that after creating MOD RNA on plasmids, the plasmid DNA remained and much of it could not be destroyed. They reference Kevin MacKurn’s discovery three years ago that vials were full of plasmid DNA, the whole plasmid and parts of it, and note that authorities allegedly minimized the issue, arguing that it doesn’t matter and that vaccines have saved millions of lives. The speaker asserts that the DNA in the vaccine vials was packaged in lipid nanoparticles and that this DNA would enter human cells. They reference colleagues’ publication last year (the INMODEO publication) showing that the DNA in the vaccine vials entered cells in culture and remained stable in cells for days, just as the MOD RNA did. Despite this, they say authorities dismissed the concerns with reassurance that nothing would happen. A pivotal point is attributed to a recent discovery by Kevin MacKinnon, claimed to be three weeks old, about what happens during transcription in the chromosome. The speaker explains that during production, byproducts occur and some mRNA strands do not detach from the DNA where they are formed, resulting in hybrids of DNA and RNA that come off together. The hybrids are described as dangerous, akin to “sparks of a sparkler,” and the speaker emphasizes that RNase H is an enzyme in the cell that takes care of these sparks and extinguishes them immediately. The speaker states that normal physicians don’t know about this, and they had to read up on RNase H after Jessica urged them to. The claimed consequence of failing to extinguish these hybrids is damage to the chromosome, with the metaphor that fires could light up and damage where they occur. The speaker asserts this could lead to “any illness that you see in the textbooks of medicine,” including tumors, neoplastic disease, autoimmune disease, developmental impairment, and death. They warn that the book of life—the genes and chromosomes—could be set on fire if these hybrids are not neutralized. The speaker says they have given interviews weekly, including one with Gary Null, and allege that this information is spreading worldwide. They claim that this situation is akin to attempted murder and exhort physicians globally not to participate, promising that those who do will be charged. They claim this issue is not limited to COVID vaccines but applies to all MOD RNA vaccines, including a flu MOD RNA vaccine now in use, and possibly veterinary vaccines, which they claim will be heavily contaminated with deadly dangerous hybrids. They urge authorities and controlling bodies to act, warning that they will face court if they fail to address the issue.

RNA sequencing of the Moderna vaccine's three prime ends suggests a possible mechanism for RNA persistence: in vivo re-adenylation. The data indicates plasmid DNA contamination despite efforts to reduce it. The data also reveals contamination from other mRNA vaccines in Moderna's pipeline. The speaker suggests that with widespread DNA sequencing capabilities, tolerating incorrect RNA sizes in vaccines is irresponsible. Sequencing before approval would have allowed for a better understanding of low RNA scores before global administration.